Anticancer vaccination strategies

被引：22

作者：

Nencioni, A ^{[1
]}

Grünebach, F

Patrone, F

Brossart, P

机构：

[1] MIT, Ctr Canc Res, Cambridge, MA 02139 USA

[2] Univ Genoa, Dept Internal Med, I-16126 Genoa, Italy

[3] Univ Tubingen, Dept Hematol Oncol & Immunol, Tubingen, Germany

来源：

ANNALS OF ONCOLOGY | 2004年 / 15卷

关键词：

D O I：

10.1093/annonc/mdh920

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：153 / 160

页数：8

共 60 条

[1] CROSS-PRIMING OF MINOR HISTOCOMPATIBILITY ANTIGEN-SPECIFIC CYTOTOXIC T-CELLS UPON IMMUNIZATION WITH THE HEAT-SHOCK PROTEIN GP96 [J].

ARNOLD, D ;

FAATH, S ;

RAMMENSEE, HG ;

SCHILD, H .

JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 182 (03) :885-889

[2] Dendritic cells as vectors for therapy [J].

Banchereau, J ;

Schuler-Thurner, B ;

Palucka, AK ;

Schuler, G .

CELL, 2001, 106 (03) :271-274

[3] Immunobiology of dendritic cells [J].

Banchereau, J ;

Briere, F ;

Caux, C ;

Davoust, J ;

Lebecque, S ;

Liu, YT ;

Pulendran, B ;

Palucka, K .

ANNUAL REVIEW OF IMMUNOLOGY, 2000, 18 :767-+

[4] Vaccination of metastatic melanoma patients with autologous tumor-derived heat shock protein gp96-peptide complexes:: Clinical and immunologic findings [J].

Belli, F ;

Testori, A ;

Rivoltini, L ;

Maio, M ;

Andreola, G ;

Sertoli, MR ;

Gallino, G ;

Piris, A ;

Cattelan, A ;

Lazzari, I ;

Carrabba, M ;

Scita, G ;

Santantonio, C ;

Pilla, L ;

Tragni, G ;

Lombardo, C ;

Arienti, F ;

Marchianò, A ;

Queirolo, P ;

Bertolini, F ;

Cova, A ;

Lamaj, E ;

Ascani, L ;

Camerini, R ;

Corsi, M ;

Cascinelli, N ;

Lewis, JJ ;

Srivastava, P ;

Parmiani, G .

JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (20) :4169-4180

[5] CD91: a receptor for heat shock protein gp96 [J].

Binder, RJ ;

Han, DK ;

Srivastava, PK .

NATURE IMMUNOLOGY, 2000, 1 (02) :151-155

[6] Induction of cytotoxic T-lymphocyte responses in vivo after vaccinations with peptide-pulsed dendritic cells [J].

Brossart, P ;

Wirths, S ;

Stuhler, G ;

Reichardt, VL ;

Kanz, L ;

Brugger, W .

BLOOD, 2000, 96 (09) :3102-3108

[7] Identification of HLA-A2-restricted T-cell epitopes derived from the MUC1 tumor antigen for broadly applicable vaccine therapies [J].

Brossart, P ;

Heinrich, KS ;

Stuhler, G ;

Behnke, L ;

Reichardt, VL ;

Stevanovic, S ;

Muhm, A ;

Rammensee, HG ;

Kanz, L ;

Brugger, W .

BLOOD, 1999, 93 (12) :4309-4317

[8] Induction of minor histocompatibility antigen HA-1-specific cytotoxic T cells for the treatment of leukemia after allogeneic stem cell transplantation [J].

Brossart, P ;

Spahlinger, B ;

Grünebach, F ;

Stuhler, G ;

Reichardt, VL ;

Kanz, L ;

Brugger, W .

BLOOD, 1999, 94 (12) :4374-4376

[9] Generation of functional human dendritic cells from adherent peripheral blood monocytes by CD40 ligation in the absence of granulocyte-macrophage colony-stimulating factor [J].

Brossart, P ;

Grünebach, F ;

Stuhler, G ;

Reichardt, VL ;

Möhle, R ;

Kanz, L ;

Brugger, WR .

BLOOD, 1998, 92 (11) :4238-4247

[10] Autografting followed by nonmyeloablative immunosuppressive chemotherapy and allogeneic peripheral-blood hematopoietic stem-cell transplantation as treatment of resistant Hodgkin's disease and non-Hodgkin's lymphoma [J].

Carella, AM ;

Cavaliere, M ;

Lerma, E ;

Ferrara, R ;

Tedeschi, L ;

Romanelli, A ;

Vinci, M ;

Pinotti, G ;

Lambelet, P ;

Loni, C ;

Verdiani, S ;

De Stefano, F ;

Valbonesi, M ;

Corsetti, MT .

JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (23) :3918-3924

← 1 2 3 4 5 6 →